HAWTHORNE, N.Y.--(BUSINESS WIRE)-- Taro Pharmaceutical Industries Ltd. (NYS: TARO) ("Taro") reported today that it has received approval from the U.S. Food and Drug Administration ("FDA") for its New ...

HAWTHORNE, N.Y.--(BUSINESS WIRE)-- Taro Pharmaceutical Industries Ltd. (TARO) ("Taro") reported today that it has received approval from the U.S. Food and Drug Administration ("FDA") for its New Drug ...

Sun Pharmaceutical’s U.S.-based Taro Pharmaceutical Industries helped the Indian drugmaker boost its U.S. sales in its last fiscal year, but the skin care specialist has hit a small manufacturing ...

Desoximetasone 0.25%. Avoid use on eyes, face, axilla, or groin. Do not use on pre-existing skin atrophy. Risk of HPA axis suppression with high-potency steroids, prolonged use, application to large ...

Perrigo Company plc PRGO recently announced that the FDA has approved its first-to-file AB rated generic version of Taro Pharmaceuticals USA Inc.'s TARO Topicort spray, 0.25% (desoximetasone topical ...

Jan 11 (Reuters) - Lupin Ltd : * Lupin receives FDA approval for generic Topicort LP Emollient cream, 0.05% and Topicort cream, 0.25% Sign up here. * Products are indicated for the relief of the ...

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their ...

Lupin Ltd has informed BSE regarding a Press Release dated December 14, 2016 titled "Lupin Receives FDA Approval for Generic Topicort Advisory Alert: It has come to our attention that certain ...

HAWTHORNE, N.Y. — Taro Pharmaceutical Industries reported last week that it has received approval from the Food and Drug Administration for its new drug application Topicort (desoximetasone) topical ...